Conference Description:

The 13th Annual Next Generation Protein Therapeutics and Bioconjugates Summit delivers the very latest results from an ever-expanding number of multifunctional molecules in development and offers you the best opportunity to learn from world-renowned academics and industry visionaries who are expanding the frontiers of biologic drugs.

Hear from the best and the brightest speakers spanning across industry and academia:

FDA Feedback: Regulatory Guidance and Expectations for Next Generation Protein Therapeutics and Bioconjugates
Presented by: Christopher Sheth, Supervisory Pharmacologist, Division of Hematology Oncology Toxicology, FDA

From Antibodies to Synthetic Proteins
Presented by: Sachdev Sidhu, Professor, Donnelly Centre, University of Toronto

Lessons Learned from the Clinical Development of ADCs: Moving Forward
Presented by: Rakesh Dixit, Vice President RandD, Global Head, Biologics Safety
Assessment, MedImmune Inc.

By attending, you will gain valuable knowledge from more than 35 presentations showcasing new, unpublished data, and exclusive case studies to help you:

Determine what modalities are moving the needle
Evaluate creative protein engineering and design approaches for non mAb products
Learn how the next generation of targets will be identified and what challenges are anticipated
Discover where the future lies for bioconjugates beyond cytotoxins
Development of next generation conjugation techniques
Apply new technologies for challenging targets
Achieve delivery into cells and across the blood-brain barrier
Gain lessons learnt from translation from discovery to the clinic
Uncover what the regulatory expectations are for next generation therapeutics and bioconjugates

Time: 7:00 am to 4:20 pm

Prices:
Industry Rate: All Access Pass Save 400 when you book by April 20th: USD 2699.0,
Industry Rate: Next Generation Protein Therapeutics Summit Pass Save 400 when you book by April 20th: USD 2299.0,
Academic/Government Rate: All Access Pass: USD 1099.0,
Academic/Government Rate: Next Generation Protein Therapeutics Summit Pass: USD 699.0